Carbon monoxide (CO) is one of the most harmful gases inhaled when smoking. It is invisible, odorless, and tasteless, yet it has immediate and significant effects on the body.
Carbon monoxide is produced whenever carbon-containing materials, such as tobacco, burn incompletely. When a cigarette is lit, it generates CO that is inhaled into the lungs and rapidly passes into the bloodstream. There, it binds strongly to hemoglobin, the molecule responsible for carrying oxygen. This binding forms carboxyhemoglobin, which reduces the blood’s capacity to transport oxygen to tissues and organs.
Each cigarette causes a measurable rise in carbon monoxide levels. After smoking a single cigarette, carboxyhemoglobin levels in the blood typically increase to around 3 to 6 percent. In people who smoke regularly, especially those consuming a pack per day, these levels often remain between 5 and 10 percent, and can be even higher in heavy smokers. By contrast, non-smokers usually have levels between 0.5 and 1 percent, meaning that smokers may carry five to ten times more carbon monoxide in their blood.
This difference is also reflected in exhaled air. In non-smokers, exhaled carbon monoxide levels are usually very low, typically around 1 to 5 parts per million (ppm). In smokers, however, exhaled CO commonly ranges from about 10 to 30 ppm, and can exceed this range depending on how recently and how heavily the person has smoked. These measurements are often used in smoking cessation programs to provide visible feedback on exposure.
Consequences:
The presence of carbon monoxide in the blood reduces oxygen delivery throughout the body, which has widespread consequences. In the short term, this leads to reduced physical performance, increased breathlessness, headaches, and a higher heart rate as the body attempts to compensate for the lack of oxygen. Over time, the strain on the cardiovascular system contributes to the development of heart disease and stroke. Carbon monoxide also damages blood vessels and accelerates the process of atherosclerosis. In individuals with existing conditions such as angina or chronic obstructive pulmonary disease, the effects can be particularly severe. In pregnant women, carbon monoxide exposure reduces oxygen supply to the fetus, increasing the risk of low birth weight and developmental complications.
How quickly does carbon monoxide disappear after quitting?
One of the most encouraging aspects of carbon monoxide exposure is how quickly the body begins to recover after smoking stops. Within about eight hours of the last cigarette, carbon monoxide levels in the blood drop by roughly half. Within 12 to 24 hours, levels return close to those seen in non-smokers. After about 48 hours, carbon monoxide is essentially eliminated from the bloodstream. As this happens, oxygen delivery improves rapidly, and many people begin to notice that breathing becomes easier and energy levels increase within a very short time.
When a cigarette burns, the combustion process acts like a mini chemical factory, creating toxic substances that are not present in unburned tobacco and releasing a cloud of smoke containing thousands of compounds, many of which are highly toxic, carcinogenic, or pharmacologically active. Smoke is the real disease vector, attacking virtually every system in the body with each inhalation. Understanding the types of substances present and how manufacturers design them is essential to grasping the health risks of smoking.
The Three Classes of Toxic Agents
Cigarette smoke is typically analyzed by dividing its components into two main phases: the particulate phase (tiny solid particles and liquid droplets) and the gas phase. Within these phases, the toxic substances fall into three broad categories:
Carcinogens (Cancer-Causing Agents): These are perhaps the most feared components. Cigarette smoke contains at least 70 known human carcinogens. These chemicals damage DNA, the blueprint of the cell, leading to uncontrolled growth and tumor formation. Prominent examples include:
Polycyclic Aromatic Hydrocarbons (PAHs): Found in coal tar and automobile exhaust, PAHs are potent DNA damagers.
Nitrosamines (NNN and NNK): These are tobacco-specific carcinogens formed during the curing and burning of the tobacco leaf.
Aromatic Amines (e.g., 4-aminobiphenyl): Linked strongly to bladder cancer, these compounds are highly toxic even at low concentrations.
Pharmacologically Active and Addictive Agents: The most dominant of these is nicotine, but other substances modulate its effect and overall toxicity.
Nicotine: The primary addictive agent. While not a major cause of cancer itself, nicotine acts on the brain to drive dependence. It elevates heart rate and blood pressure, placing significant stress on the cardiovascular system.
Monoamine Oxidase (MAO) Inhibitors: As discussed previously, these compounds found in smoke artificially boost mood-regulating chemicals like dopamine in the brain, enhancing the addictive power of nicotine and making withdrawal more difficult.
Toxic and Respiratory Irritants: These compounds damage the airways and interfere with the body’s ability to use oxygen.
Carbon Monoxide (CO): A colorless, odorless, deadly gas. CO is inhaled and quickly binds to hemoglobin in the blood, displacing oxygen. This reduces the oxygen-carrying capacity of the blood, starving organs, including the heart and brain, of necessary oxygen. This oxygen deprivation, known as hypoxia, is a major contributor to cardiovascular disease in smokers.
Hydrogen Cyanide: A chemical warfare agent, this gas impairs the lungs’ natural cleaning system—the cilia—making it harder for the lungs to clear mucus and foreign particles, thereby increasing the risk of infection and chronic inflammation.
Acrolein and Ammonia: Both are highly irritating gases that damage the delicate lining of the airways and alveoli, directly contributing to the inflammation and destruction seen in Chronic Obstructive Pulmonary Disease (COPD).
How Manufacturers Engineer Nicotine Dosage
The tobacco industry employs highly precise engineering to ensure the maximum, addictive delivery of nicotine, often with the same chemical rigor used in pharmaceutical manufacturing. This control is achieved through three main levers:
Ammonia Technology: By treating tobacco with ammonia or its compounds, manufacturers increase the alkalinity (pH) of the smoke. This process converts the bound nicotine in the tobacco into its “freebase” form. Freebase nicotine is vaporized more easily and absorbed into the bloodstream far more quickly and intensely, producing a rapid, powerful “hit” that maximizes the addictive potential of the product.
Filter and Ventilation Control: As discussed previously, while filters outwardly suggest reduced harm, the tiny ventilation holes laser-perforated into the filter paper are designed to game machine testing. They dilute the smoke when measured, allowing “low-tar” claims. In real-world use, however, smokers instinctively cover these holes or inhale more deeply to get their required dose of nicotine, effectively bypassing the filter’s diluting function. This engineering ensures that the intended addictive dose is always met.
Controlling the Smell (Odor) of Secondhand Smoke
The perception of cigarette smoke—the harshness and the lingering odor—is a factor that can deter non-smokers and affect social tolerance of the product. Manufacturers have, over time, used additives not just to improve the taste for the user, but to modify the odor of the side-stream smoke (the smoke coming directly from the burning tip).
Flavorings and aromatic compounds are included to create a more “pleasant” aroma, making the smoke less irritating to bystanders and potentially reducing the social stigma associated with smoking in certain environments. This chemical masking is a strategic move to maintain social acceptance and increase the perceived appeal of the product, despite the unchanged underlying toxicity of the thousands of chemicals in the aerosol.
The cigarette, therefore, is not a simple natural product. It is a highly engineered, chemically saturated delivery system designed to addict the user and facilitate the transport of hundreds of poisons directly into the body, a process that is precisely controlled from the tobacco field to the filter tip.
Most smokers know nicotine is what keeps them smoking. Fewer know how much nicotine is in a cigarette, how much actually reaches the brain, or why cigarettes deliver it so effectively. Understanding this makes it easier to choose the right support when you quit smoking.
Most commercial cigarettes contain about 10 to 15 mg of nicotine in the tobacco. You don’t absorb all of that. Much of it is destroyed by burning, left in the butt, or lost in the smoke that drifts away between puffs. A typical smoker absorbs about 1 to 2 mg per cigarette. That may sound small, but it is enough to create and maintain nicotine addiction.
Why cigarettes are so addictive
Speed of delivery is the key factor. Inhaled nicotine reaches the brain within about 10 seconds, triggering a release of dopamine that feels rewarding or calming. Nicotine then clears from the body fairly quickly, and levels fall by half within about 90 minutes, and withdrawal symptoms such as irritability, cravings and poor concentration begin to build. The next cigarette relieves them, and the cycle repeats. Over time the brain adapts and comes to expect regular doses.
Manufacturers have also designed cigarettes to make nicotine delivery fast and reliable, through tobacco blending, chemical additives that make the smoke easier to inhale, and by spraying nicotine on tobacco during manufacture.
“Light”, “mild” and “low-nicotine” cigarettes
Cigarettes once sold as “light”, “mild” or “low nicotine” (labels now banned in many countries) contain about as much nicotine in the tobacco as regular ones. They produce lower nicotine yields on testing machines because tiny ventilation holes near the filter dilute the smoke, but smokers don’t smoke like machines. Because the brain wants its usual dose, people who smoke these cigarettes tend to compensate by:
taking deeper or longer puffs,
smoking more cigarettes, and
covering the vent holes with their fingers or lips.
The result is that they get a roughly similar dose of nicotine and the same toxic smoke for regular and “light” cigarettes.
Genuinely very-low-nicotine cigarettes (VLNC), which contain almost no nicotine in the tobacco, are different. In research trials they have reduced dependence and the number of cigarettes smoked, which is why some governments are considering limits on nicotine content, but this policy is controversial, because some experts think that people will not use VLNC in the long term. They are not widely available, and they are not a safe cigarette either, since the smoke is still harmful.
Nicotine is addictive, but smoke is what does most of the damage
Nicotine isn’t harmless. It is addictive, it temporarily raises heart rate and blood pressure, and it should be avoided in pregnancy unless a doctor advises otherwise. But the cancers, lung diseases and heart diseases caused by smoking comes from burning tobacco and inhaling smoke: tar, carbon monoxide and thousands of other chemicals. This is why delivering nicotine without smoke is much safer than smoking, and why it can help you stop smoking.
What can help you quit smoking?
Nicotine replacement therapy (NRT) in the form of patches, gum, lozenges, tablets, inhalers or sprays gives you nicotine at a slower, steadier rate than a cigarette, without the smoke. This relieves cravings and withdrawal while you break the habit. Because nicotine is absorbed gradually rather than hitting the brain within seconds, NRT has a much lower potential for dependence than cigarettes, though a small number of people do continue using nicotine gums for longer than planned. Nobody is addicted to the nicotine patch, because of its very slow nicotine delivery.
Combination NRT works better. Using a patch for steady background nicotine plus a fast-acting form (gum, lozenge or spray) for sudden cravings improves the chances of quitting compared with a single product.
Dose matters. Heavier smokers (for example those who smoke 10 or more cigarettes a day, or light up within 30 minutes of waking) usually need a higher-strength patch or gum. Too little nicotine is a common reason for relapse. A pharmacist or doctor can help you choose the best product and the right dosage.
Prescription medicines such as varenicline and cytisine / cytisinicline reduce cravings and the reward from smoking, and in studies they are among the most effective options. Bupropion is another choice. Availability varies by country.
Nicotine e-cigarettes have helped many people stop smoking, and recent reviews suggest they are more effective than NRT and as affective as varenicline. They are much less harmful than cigarettes, but not risk-free, and long-term effects are still being studied. They are intended for smokers who want to quit, not for non-smokers.
Nicotine pouches have been studied less, and rules on their sale differ between countries.
Support increases success.Counselling, quitline calls and peer groups help with the habits, routines and emotions linked to smoking, and work well alongside medication.
Find out how much nicotine you need
Take our quiz to estimate how much nicotine you inhale (or inhaled) as a smoker, and what dosage of nicotine suits you best.
What to expect after quitting
Withdrawal symptoms usually peak within the first weeks and then ease. These include cravings, irritability, trouble sleeping, difficulty concentrating and increased appetite and weight gain. These symptoms are attenuated by nicotine medications. Cravings come in waves that pass, even if you do nothing. Slips happen and are not failure. Many people need more than one attempt, and each attempt teaches you something.
take regular medication or have a medical condition.
Most people can safely use NRT, and the risks of continuing to smoke are far greater, but a doctor or pharmacist can tailor advice to you.
Rate this article by clicking on the desired number of stars: (3 votes, average: 5.00 out of 5)
Please use the “Comments” field below to share your experience or suggest improvements to this article.
References:
Theodoulou A, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J, Livingstone-Banks J, Hajizadeh A, Lindson N. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 2023, Issue 6. Art. No.: CD013308. https://doi.org/10.1002/14651858.CD013308.pub2
Djordjevic, M.V., Doran, K. . (2009). Nicotine Content and Delivery Across Tobacco Products. In: Henningfield, J.E., London, E.D., Pogun, S. (eds) Nicotine Psychopharmacology. Handbook of Experimental Pharmacology, vol 192. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69248-5_3
Djordjevic, M.V., Doran, K. . (2009). Nicotine Content and Delivery Across Tobacco Products. In: Henningfield, J.E., London, E.D., Pogun, S. (eds) Nicotine Psychopharmacology. Handbook of Experimental Pharmacology, vol 192. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69248-5_3
Martin J. Jarvis, Richard Boreham, Paola Primatesta, Colin Feyerabend, Andrew Bryant, Nicotine Yield From Machine-Smoked Cigarettes and Nicotine Intakes in Smokers: Evidence From a Representative Population Survey, JNCI: Journal of the National Cancer Institute, Volume 93, Issue 2, 17 January 2001, Pages 134–138, https://doi.org/10.1093/jnci/93.2.134
Malson JL, Sims K, Murty R, et al. Comparison of the nicotine content of tobacco used in bidis and conventional cigarettes. Tobacco Control 2001;10:181-183. https://doi.org/10.1136/tc.10.2.181
